Studying ARDS to improve care
Part of Infections, Lungs & breathing clinical trials.
This study collects health information from ICU patients with or at high risk for ARDS to better understand the condition and develop a tool to help doctors make decisions. It may not directly help you, but it could improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- In the intensive care unit (ICU)
- Have a lung condition called ARDS, or are at high risk for it
- Not have a tracheostomy (breathing tube through the neck)
- Not be living in a long-term care facility
- Agree to participate and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for patients in the ICU with ARDS (a severe lung condition). It looks at biomarkers (special substances in your blood) to help understand different types of ARDS. You do not receive any treatment, but you help researchers learn more about the disease.
This study looks at the real-world features, treatments, and outcomes of people with acute respiratory distress syndrome (ARDS), a serious lung condition that makes it hard to breathe. If you are on certain types of breathing support and meet the oxygen and lung scan criteria, your participation may help improve care for others with this condition.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study examines lung fluid samples and imaging scans from patients on breathing machines to better understand acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers hope this will help doctors diagnose and treat ARDS more effectively in the future.
This study looks at different types of inflammation in patients with Acute Respiratory Distress Syndrome (ARDS), a serious lung condition. It aims to find which treatments work best for each subtype.
This trial studies how immune cells in the lungs and gut microbes (your microbiome) change during ARDS and how these changes relate to your outcomes. It may help researchers better predict and treat ARDS by learning what’s going on in the lungs and body systems.
Hear when a new Respiratory Distress Syndrome, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.